India@2047: Rajiv Podar of of Podar Enterprise Charts the Roadmap to a Global Superpower
At the prestigious 14th Annual India Leadership Conclave & Power Brand Awards 2025 held at Hotel Mumbai International Airport, Mr. Rajiv K. Podar, Chairman & Managing Director of Podar Enterprise, delivered a visionary keynote on “India@2047: Roadmap to a Developed Nation through Innovation, Inclusion, and Infrastructure.”
In his stirring address, Mr. Podar emphasized that India is steadily emerging as a global superpower, driven by the twin engines of innovation and inclusive growth. He outlined a bold roadmap where technological advancement, equitable opportunities, and world-class infrastructure will converge to transform India into a developed nation by 2047 – the centenary of independence.
Mr. Podar highlighted:
• Innovation as the cornerstone of India’s rise, with entrepreneurship and digital transformation reshaping industries.
• Inclusion as the moral imperative, ensuring that growth reaches every citizen, bridging rural-urban divides.
• Infrastructure as the backbone of progress, positioning India as a hub of global trade, investment, and sustainable development.
He concluded with a clarion call: “India’s destiny is to lead, not follow. By 2047, our nation will stand tall as a beacon of innovation, inclusivity, and resilience – a true global superpower.”
“India’s destiny is to lead, not follow. Through innovation, inclusion, and infrastructure, we will transform into a developed nation by 2047 and stand tall as a beacon of resilience and global leadership.”

India’s BRICS Chairship Delivers Consensus Amid Fractures: Practical Gains, Measured Diplomacy, and Limits of Alignment
Top 50 Entrepreneurs in Pharmaceutical Industry Powering the Global Medicine Chest
Top 10 Indian IT Giants Raise the Bar on Employee Rewards
PoK Gamble: Rhetoric Meets Realpolitik Along the Line of Control
4.3 Crore Indians Stranded in Unemployment as Youth Crisis Deepens – Network 7 Research Findings
Dr. Koushik Lahiri Issues Urgent Global Clarion Call Against Steroid Dependence Crisis at 17th Pharma Leaders Summit